SUBSTITUTED GUANIDINES FOR THE TREATMENT OF CANCER
Kind Code:
A2
Abstract not available for EP1202718

Inventors:
Lipkowski, Andrzej W. (PL)
Gee, Kelvin (US)
Application Number:
EP20000948868
Publication Date:
05/08/2002
Filing Date:
07/21/2000
View Patent Images:
Export Citation:
Assignee:
KADMUS PHARMACEUTICALS INC (US)
International Classes:
C07D295/00; C07D295/12; A61K31/155; A61K31/155; A61K31/21; A61K31/216; A61K31/222; A61K31/223; A61K31/395; A61K31/395; A61K31/40; A61K31/40; A61K31/403; A61K31/4045; A61K31/405; A61K31/428; A61K31/428; A61K31/445; A61K31/445; A61K31/4453; A61K31/4453; A61K31/451; A61K31/451; A61K31/495; A61K31/495; A61K31/7008; A61K31/7008; A61P35/00; A61P35/00; A61P43/00; A61P43/00; C07D207/00; C07D207/50; C07D209/00; C07D209/16; C07D209/18; C07D209/20; C07D211/00; C07D211/14; C07D211/52; C07D211/64; C07D273/00; C07D273/00; C07D277/00; C07D277/68; C07D277/82; C07H15/00; C07H15/04; (IPC1-7): A61K31/00; A61K31/155; A61K31/222; A61K31/40; A61K31/405; A61K31/445; A61K31/495; A61K31/7008; A61P35/00
European Classes:
A61K31/155; A61K31/216; A61K31/222; A61K31/395+A; A61K31/40; A61K31/40+A; A61K31/4045; A61K31/405; A61K31/428; A61K31/445; A61K31/451; A61K31/495; A61K31/495+A; A61K31/7008; C07D209/16; C07D209/18; C07D209/20; C07D211/52; C07D211/64; C07D273/00J; C07D277/68B; C07D277/82




<- Previous Patent (USE OF NAALADASE INH...)   |   Next Patent (ANESTHETIC COMPOSITI...) ->